The 16-Point MSIDS Model for Complex Chronic Illness

When Dr. Richard Horowitz describes complex chronic illness, he commonly uses a simple but powerful analogy: imagine going to the doctor with 16 nails in your foot. 

 

If only one or two nails are removed, you may feel some relief, but you’re still going to hurt because the remaining nails continue to drive the problem. His point is that many chronically ill patients aren’t dealing with one isolated root cause. 

 

They oftentimes have multiple overlapping factors keeping the body inflamed and preventing meaningful recovery.

 

This is similar to the toxin bucket theory we frequently discuss. The body can usually compensate for a certain amount of stress, inflammation, exposure, infection, and dysfunction. But as more stressors accumulate, that bucket can eventually overflow. At that point, the trigger that seems to have caused everything may simply have been the final addition to a much larger burden. Removing one trigger can certainly help, but lasting healing may require understanding what else is still filling the bucket.

 

This is where the MSIDS model offers a different lens for complex chronic illness. 

 

Rather than asking which single diagnosis explains every symptom, the framework encourages us to look at the broader landscape of factors that may be interacting, amplifying one another, or keeping the body stuck. In our recent conversation with Horowitz, we explored how this model can change the way we think about patients who have been sick for years, collected multiple diagnoses, or treated one suspected root cause only to find that they still aren’t fully well. 

 

Understanding that bigger picture can be one of the missing pieces for finally making sense of complex chronic illness.

 

Key Takeaways

• MSIDS is a 16-point framework for complex chronic illness that looks beyond a single diagnosis to identify overlapping root causes and downstream dysfunction.
• Lyme disease can be one piece of MSIDS, but it may not explain the entire health picture, especially when multiple systems are affected.
• Chronic infections and environmental toxins often sit near the top of the MSIDS map, while gut, immune, hormonal, autonomic, mitochondrial, nutritional, and sleep dysfunction can further complicate recovery.
• MSIDS and CIRS can overlap significantly, but they are not the same condition, with CIRS potentially representing one important part of a broader MSIDS presentation.
• Patterns across symptoms can be just as important as individual diagnoses, particularly when symptoms fluctuate, migrate, or affect several body systems at once.
• Treatment order matters in complex chronic illness, and the best starting point depends on the patient’s biggest drivers, tolerance, and what may be blocking progress.
• Treating an infection or removing an exposure may not resolve every downstream effect, which is why foundational and multisystem support can remain important even after a major trigger improves.
• Nervous system regulation can be an important part of root-cause healing without suggesting that chronic illness is psychological, and it should complement rather than replace physiological treatment.
• MSIDS testing should be individualized, since test methodology, timing, immune function, species or strains, and clinical context can all influence how results are interpreted.
• Recovery can take time, but chronic illness does not necessarily mean permanent illness, and meaningful improvement can occur well before every layer of dysfunction has been resolved.

 

 

Pro-Tip: If the MSIDS model resonates with you or you feel overwhelmed trying to make sense of multiple diagnoses, overlapping symptoms, and possible root causes, you don’t have to navigate complex chronic illness alone. Our functional medicine practitioners at Empower Functional Health take a comprehensive, personalized approach to identifying the factors that may be contributing to your health picture and determining what to prioritize first. Our Personalized Health Plan is the starting point for working with our team and is designed to help bring your history, symptoms, labs, lifestyle, and potential root causes together into a clearer path forward.

 

 

What Is MSIDS?

 

 

MSIDS, or Multiple Systemic Infectious Disease Syndrome, is a 16-point clinical framework developed by Dr. Richard Horowitz to help identify the overlapping factors that can contribute to complex chronic illness. 

 

Rather than viewing persistent illness through the lens of one symptom, diagnosis, or body system, the MSIDS model provides a structured way for practitioners to investigate the different contributors that may be driving inflammation, interfering with recovery, or causing symptoms to persist. Horowitz has described the framework as a practical map that clinicians can work through systematically while still individualizing evaluation and care to the individual in front of them.

 

The model grew out of Horowitz’s decades of clinical work with some of the most difficult chronic illness cases. Horowitz has spent more than 40 years caring for approximately 13,000 chronically ill patients, many of whom had already seen numerous specialists without finding a complete explanation for why they remained sick. 

 

Early in his career, he became frustrated watching patients continue to relapse despite being referred across different specialties. Instead of accepting that there was no further explanation, he began looking more closely at the patterns these patients shared and the additional factors that could be preventing recovery.

 

Over time, those recurring patterns evolved into the MSIDS framework. Horowitz has explained that he gave these interconnected factors the MSIDS name so they could be organized into a memorable, reproducible model rather than approached as disconnected abnormalities. 

 

His earlier work introduced the framework in Why Can’t I Get Better?, while his newer book, Ending Chronic Illness, expands the model into a broader approach for investigating complex chronic disease. Today, Horowitz is an internationally recognized physician and author known for his work in complex chronic and tick-borne illness; he has also trained hundreds of physicians in the MSIDS model and helped found the International Lyme and Associated Diseases Society (ILADS).

 

You can read Horowitz’s most recent content through his Medical Detective Substack.

 

What Does Multiple Systemic Mean?

 

 

The “multiple systemic” part of MSIDS reflects a central idea that complex chronic illness typically doesn’t stay confined to one organ or body system. Instead, several systems can become disrupted at the same time and begin influencing one another, creating a much broader pattern of symptoms than we would expect from looking at any one system in isolation.

 

For example, an individual may experience brain fog and mood changes alongside digestive problems, poor sleep, fatigue, dizziness, hormone imbalances, and pain. On the surface, these can look like unrelated complaints requiring different specialists. 

 

The MSIDS model instead asks whether these symptoms may be part of an interconnected picture involving several areas of physiology at once. 

 

System or Area	What Dysfunction May Look Like
Immune	Excessive inflammation, immune suppression, or abnormal immune responses
Nervous system	Brain fog, cognitive changes, neurological symptoms, altered stress responses, or physical symptoms
Autonomic nervous system	Problems regulating heart rate, blood pressure, temperature, or other automatic functions
Gastrointestinal	Digestive dysfunction and changes in the gut environment
Endocrine	Disrupted hormone regulation
Mitochondrial	Reduced cellular energy production and fatigue
Nutritional	Deficiencies or imbalances that affect normal physiological function
Sleep	Difficulty getting restorative sleep, which can further affect other systems

 

These systems don’t operate independently. Poor sleep can worsen inflammation, inflammation can affect neurological and hormonal function, digestive dysfunction can influence immune activity and nutrient status, and autonomic dysfunction can affect everything from digestion to circulation. This creates a potential feedback loop in which dysfunction in one area places additional strain on several others.

 

How Is MSIDS Different From Lyme Disease?

 

 

The key difference is that Lyme disease is a specific infectious disease, while MSIDS is a broader clinical framework for understanding complex chronic illness. MSIDS asks practitioners to look at the full health picture rather than assuming one diagnosis explains every symptom. That means considering how multiple physiological systems and potential contributors may be interacting at the same time.

 

This distinction is important because someone can have a known diagnosis and still have additional factors that need attention. The 16-point MSIDS model is a way to systematically investigate those overlapping drivers rather than viewing them in isolation.

 

For some patients, Lyme disease may be one important piece of that puzzle, but it may not be the entire picture. 

 

What Are the 16 Factors in the MSIDS Model?

 

 

In the current MSIDS framework, the 16 points are organized into six primary sources of inflammation, referred to as “six rivers of inflammation,” and 10 downstream effects that can develop as that inflammatory burden affects different systems throughout the body. 

 

Some factors may help drive the inflammatory process, while others may be consequences of that inflammation that then create additional barriers to recovery.

 

Group	#	MSIDS Factor	What It Means
Primary sources of inflammation	1	Chronic infections	Persistent or reactivated bacterial, viral, parasitic, and fungal infections can continually stimulate the immune system and inflammatory response.
	2	Environmental toxins	Mold toxins, heavy metals, pesticides, and other environmental exposures may increase oxidative stress, inflammation, and total toxic burden.
	3	Gut microbiome imbalances	Dysbiosis, or an unhealthy balance of intestinal microorganisms, can alter immune signaling, digestion, metabolic health, and the gut-brain connection.
	4	Leaky gut, food sensitivities, and mast cell activation	Increased intestinal permeability and abnormal reactions to foods or other triggers can continually activate immune and inflammatory pathways.
	5	Sleep disorders	Inadequate or disrupted sleep can independently increase inflammatory signaling while also making it harder for the body to repair and regulate other systems.
	6	Vitamin, mineral, and nutritional deficiencies	Inadequate levels of nutrients needed for immune function, energy production, antioxidant defenses, detoxification, and tissue repair can reduce the body’s ability to recover.
Downstream effects of inflammation	7	Hormonal and endocrine dysfunction	Chronic inflammation can disrupt thyroid, adrenal, sex hormone, blood sugar, and other endocrine pathways that regulate energy, metabolism, stress response, and overall function.
	8	Immune dysfunction	The immune system may become weakened, imbalanced, or less capable of appropriately responding to infections and other threats.
	9	Autoimmunity	Loss of normal immune tolerance can contribute to the production of antibodies or immune responses directed against the body’s own tissues.
	10	Neurological dysfunction	Inflammation affecting the nervous system may contribute to cognitive problems, neuropathy, headaches, sensory changes, and other neurological symptoms.
	11	Psychological and neuropsychiatric dysfunction	Anxiety, depression, mood changes, trauma-related patterns, and other psychological or neuropsychiatric symptoms may develop alongside—and interact with—chronic physiological illness.
	12	POTS and autonomic nervous system dysfunction	Dysautonomia can impair the automatic regulation of heart rate, blood pressure, circulation, digestion, bladder function, temperature regulation, and other involuntary processes.
	13	Mitochondrial dysfunction	Oxidative stress and chronic inflammation can interfere with the mitochondria’s ability to efficiently produce cellular energy, potentially contributing to persistent fatigue and poor recovery.
	14	Pain syndromes	Chronic muscle, joint, nerve, headache, and other pain patterns can emerge from ongoing inflammatory, neurological, immune, and musculoskeletal dysfunction.
	15	Liver and metabolic dysfunction	Inflammation and metabolic stress can affect liver function, detoxification, blood sugar regulation, and conditions such as fatty liver disease.
	16	Physical deconditioning	Months or years of fatigue, pain, dizziness, or exercise intolerance can lead to loss of muscle strength and physical capacity, which can become another obstacle to recovery.

 

The model doesn’t assume that every chronically ill patient has all 16 factors or that every factor carries equal weight. Instead, it gives practitioners a systematic way to ask which nails are actually present for that individual and which ones may be most responsible for keeping the inflammatory cycle going.

 

Why Infections and Environmental Toxins May Sit Near the Top of the MSIDS Map

 

 

While every MSIDS case is individualized, Horowitz consistently places chronic infections and environmental toxins near the top of the map because they can act as ongoing sources of immune activation and inflammation. He groups infectious contributors broadly into bacterial, parasitic, viral, and fungal infections, while also prioritizing environmental burdens such as mold toxins and heavy metals. In his clinical experience, these two categories are often among the most important inflammatory drivers to investigate in complex chronic illness.

 

Lyme Disease and Borrelia

 

 

Lyme disease is caused by bacteria belonging to the Borrelia group and remains an important part of Horowitz’s work, but within MSIDS it is evaluated as one potential infectious driver. One challenge he highlights is the ability of Borrelia to persist in different forms, including biofilm-associated persister forms that may become less metabolically active and more difficult to identify or address. 

 

Bartonella

 

 

Horowitz places particular emphasis on Bartonella, another bacterial infection that he believes is frequently overlooked in complex chronic illness. He notes that there are numerous pathogenic Bartonella species and that Bartonella can also behave as an intracellular, biofilm-associated persister organism. It has a wide range of fatigue, musculoskeletal, neurological, cognitive, and neuropsychiatric presentations, and Bartonella exposure is available from different insects and animals.

 

Babesia

 

 

Babesia is a parasitic infection rather than a bacterium, and it represents another major infectious category. Horowitz specifically discusses multiple Babesia species, including Babesia microti, B. duncani, and B. odocoilei, noting that different species may not behave or respond identically. Clinically, symptoms such as unexplained sweats and air hunger can provide clues that Babesia may warrant further investigation. Galaxy Diagnostics has found that skin sensations are one of the most common symptoms.

 

Other Parasitic Infections

 

 

Parasitic infections are another potential source of ongoing immune activation and inflammation, and are more relevant in the US than many individuals realize. Parasites can be acquired domestically through food, water, animals, soil, or other environmental exposures. Parasite testing has important limitations: detection can depend on the organism being tested for, the type of test used, timing, and whether the parasite is being shed or detectable at the time the sample is collected. A single negative stool or blood test therefore may not always fully rule out infection, particularly when the clinical history and symptom pattern remain suspicious. This is why parasitic infections can warrant consideration when digestive symptoms, unexplained inflammation, nutrient abnormalities, food sensitivities, or other clinical clues suggest the possibility.

 

Viruses and Viral Reactivation

 

 

MSIDS also considers active viral infections and the reactivation of viruses that the immune system had previously kept under control. Horowitz discusses COVID-19 alongside reactivation of viruses such as Epstein-Barr virus (EBV) and HHV-6, particularly when illness places additional strain on immune function. This helps explain why a viral illness may sometimes act as a tipping point.

 

Fungal Overgrowth and Mold-Related Illness

 

 

The fungal category can include both internal fungal overgrowth, such as Candida and small intestinal fungal overgrowth (SIFO), and illness associated with environmental mold and mycotoxins. Fungal colonization, fungal biofilms, and mold toxins are potential contributors to the inflammatory burden. Mold can be particularly complex because it may involve an ongoing environmental exposure as well as downstream effects on immune and mitochondrial function.

 

Heavy Metals and Other Environmental Toxins

 

 

Heavy metals and other toxic exposures are additional contributors that should be considered when the history warrants it. Looking for mold toxins, heavy metals, and other toxins alongside infections, the microbiome, sleep, and other MSIDS factors is essential. 

 

MSIDS vs. CIRS

 

 

Mold exposure can affect the body in several different ways, which is one reason the term mold illness can mean very different things from one patient to another. 

 

Water-damaged environments can contribute to a variety of mold-related conditions, including mold allergies, fungal colonization, invasive mold, and chronic mold illness. For some individuals, the concern extends to a much broader inflammatory response affecting multiple systems. 

 

Mold and environmental toxins are high on the MSIDS map because of their ability to impact various systems and cause a wide range of downstream effects. Patients who are particularly mold-sensitive may need their environmental and mold burden addressed before other parts of the MSIDS picture can be tackled effectively.

 

One specific condition associated with this type of multisystem response is Chronic Inflammatory Response Syndrome (CIRS). CIRS is an acquired, multisymptom illness characterized by persistent innate immune dysregulation following exposure to biotoxins, most commonly those associated with water-damaged buildings. It can affect neurological, hormonal, immune, vascular, metabolic, and other systems, which is why its symptoms can look so widespread and seemingly unrelated. 

 

Although MSIDS and CIRS overlap significantly, they aren’t the same model. MSIDS is a much broader framework for investigating multiple potential drivers and downstream effects of complex chronic illness, whereas CIRS can act as one of the many drivers within MSIDS that is impacting a patient.

 

	MSIDS	CIRS
Full name	Multiple Systemic Infectious Disease Syndrome	Chronic Inflammatory Response Syndrome
Primary purpose	A broad framework for identifying multiple overlapping contributors to complex chronic illness	A clinical framework for identifying a specific pattern of chronic innate immune dysregulation associated with biotoxin exposure
What may initiate illness	Potentially many factors, including infections, environmental toxins, gut dysfunction, sleep problems, nutritional deficiencies, and other inflammatory drivers	Most commonly exposure to the microbial environment of water-damaged buildings in addition to other biotoxins
Role of mold	Mold and mycotoxins fall within the environmental-toxin portion of the larger MSIDS map	Water-damaged-building exposure is a central consideration in CIRS evaluation
Role of infections	Bacterial, viral, parasitic, and fungal infections are major areas of investigation	Infections commonly coexist or complicate the picture, but infection isn’t required to define or diagnose CIRS
Immune involvement	Immune dysfunction and autoimmunity are among the many interconnected factors considered	Abnormal regulation of the innate immune response is central to the model
Systems affected	Can involve immune, gastrointestinal, neurological, autonomic, endocrine, mitochondrial, metabolic, and other systems	Also multisystem, with neurological, immune, endocrine, autonomic, vascular, and metabolic abnormalities potentially appearing
Testing approach	Guided by the patient’s history and presentation across the 16-point map; testing varies depending on suspected contributors	Uses a defined clinical history and biomarker-based workup, which includes VCS testing, bloodwork, HLA susceptibility, and other diagnostic criteria
Treatment approach	Personalized sequencing based on which MSIDS factors appear most important for the individual	Typically centers on removing ongoing exposure and following a structured, sequential, individualized Shoemaker Protocol with potential adjunct therapies
How to think about it	A map of the entire complex chronic illness picture	A specific inflammatory syndrome that may represent one important part of that picture

 

The easiest way to distinguish the two is that CIRS can potentially be one piece of an MSIDS presentation, while MSIDS asks what else may be present alongside it. 

 

What Symptoms Can Be Associated With MSIDS?

 

 

The 38-item Horowitz Lyme-MSIDS Questionnaire helps capture symptoms that patients may otherwise forget to mention. These symptoms aren’t specific to MSIDS; the value is in recognizing patterns and then investigating why they are occurring. The questionnaire itself includes the following symptom areas, with several additional symptoms discussed by Horowitz included below.

 

General, immune, and whole-body symptoms

• Persistent or unexplained fatigue and tiredness
• Unexplained fevers
• Daytime sweating or drenching night sweats
• Chills or flushing
• Unexplained weight gain or weight loss
• Swollen lymph nodes or glands
• Sore throat
• Reduced stamina or physical deconditioning
• Generalized aches and feeling chronically unwell

 

Musculoskeletal symptoms

• Joint pain or swelling
• Joint pain that changes location or migrates
• Muscle pain or myalgias
• Muscle cramps
• Migratory muscle pain
• Neck or back stiffness
• Neck cracking or persistent neck stiffness
• Rib soreness or chest-wall pain
• Muscle twitching, including twitching of the face

 

Neurological and nerve symptoms

• Headaches, including migraines
• Tingling, numbness, burning, or stabbing sensations
• Nerve pain or neuropathy
• Neuropathy that comes and goes or migrates around the body
• Internal or external vibrating sensations that may move to different areas
• Tremors
• Facial paralysis or Bell’s palsy
• Difficulty with balance or walking
• Light-headedness
• Vertigo or increased motion sickness

 

Horowitz particularly emphasizes migratory tingling, burning, stabbing, numbness, and even a moving vibration sensation.

 

Cognitive and neuropsychological symptoms

• Brain fog or difficulty thinking clearly
• Difficulty concentrating
• Difficulty reading
• Forgetfulness or poor short-term memory
• Confusion
• Becoming disoriented, getting lost, or going to the wrong place
• Difficulty speaking or writing
• Mood swings
• Irritability
• Depression
• Anxiety

 

In more severe presentations, obsessive-compulsive symptoms, hallucinations, psychosis, or bipolar-like mood changes may also be present.

 

Eyes, ears, and sensory symptoms

• Blurry vision
• Double vision
• Ringing or buzzing in the ears
• Ear pain
• Increased sensitivity to light or sound
• Dizziness
• Motion sensitivity

 

Cardiovascular and autonomic symptoms

• Heart palpitations
• Skipped or irregular-feeling heartbeats
• Heart block
• History of heart murmur or mitral valve prolapse
• Chest pain
• Light-headedness or dizziness, particularly when upright
• Low blood pressure in some patients with autonomic dysfunction
• POTS or other forms of dysautonomia

 

Autonomic dysfunction is an important part of the broader MSIDS map, and it’s recommended to evaluate changes in blood pressure and pulse with position when POTS is suspected.

 

Respiratory symptoms

• Shortness of breath
• Unexplained cough
• Air hunger, or the sensation that you can’t get a satisfying breath
• Wheezing in patients with histamine or mast-cell-related reactivity

 

Air hunger and difficulty catching the breath are symptoms patients commonly forget to report.

 

Gastrointestinal and metabolic symptoms

• Upset stomach
• Constipation
• Diarrhea
• Changes in bowel habits
• Gas
• Bloating
• Burning or significant digestive discomfort after eating
• Difficulty tolerating certain foods
• Reactive hypoglycemia or blood sugar drops after meals

 

Gut dysbiosis, Candida, intestinal permeability, and mast cell activation are overlapping MSIDS factors that can accompany significant digestive symptoms.

 

Endocrine, reproductive, and urinary symptoms

• Unexplained menstrual irregularities
• Symptoms that fluctuate around the menstrual cycle
• Breast pain
• Unexplained breast milk production
• Sexual dysfunction
• Loss of libido
• Testicular or pelvic pain
• Irritable bladder or other bladder dysfunction
• Unexplained hair loss
• Weight changes

 

Symptoms related to hormonal or adrenal dysregulation, depending on the individual.
Hormonal dysregulation and adrenal dysfunction are also included within the broader MSIDS assessment.

 

Allergic, histamine, and mast-cell-related symptoms

• Itching
• Sneezing
• Wheezing
• Increased food or histamine sensitivity
• Other allergy-like reactions

 

Sleep and recovery symptoms

• Difficulty falling asleep
• Difficulty staying asleep
• Waking too early
• Sleeping excessively
• Unrefreshing or disrupted sleep
• Worsening fatigue as poor sleep compounds other MSIDS factors

 

Other notable symptoms

• Exaggerated symptoms or an unusually severe “hangover” after alcohol
• Worsening sensitivity to environmental exposures in certain patients
• Poor exercise tolerance or loss of physical capacity after prolonged illness

 

Some complex patients may report dozens of the 38 questionnaire symptoms, while others have a much narrower pattern. 

 

Six Patterns That Can Raise Suspicion for Lyme/MSIDS

 

 

Here are the six patterns that can warrant deeper investigation into Lyme and MSIDS:

 

• Multiple multisystem symptoms: Lyme and MSIDS are usually recognized through patterns across the entire clinical picture. One of the first clues is having multiple symptoms affecting different systems at the same time. 
• Symptom fluctuation: Another pattern is that symptoms may fluctuate considerably over time, creating distinct good days and bad days. Rather than following a steady course, an individual might feel noticeably better for a period and then experience a return or worsening of symptoms. 
• Migrating symptoms: Horowitz also considers the migratory nature of symptoms particularly important. Joint pain, muscle pain, tingling, numbness, burning, or other nerve sensations may disappear from one location and later appear somewhere else in the body.
• Menstrual differences in symptoms: For women, symptoms can also change around the menstrual cycle. Some patients notice predictable worsening before, during, or shortly after their period, potentially reflecting the interaction between hormonal fluctuations and the broader inflammatory or infectious picture. 
• Changes in symptoms when taking antibiotics: A fourth pattern is an unexpected change in chronic symptoms while taking antibiotics for an unrelated reason. Some patients report temporarily feeling better, while others notice a transient worsening of symptoms that can be a Jarisch-Herxheimer die-off reaction. 
• Supportive laboratory findings: Finally, laboratory findings can add another piece of evidence when the history and symptom pattern already raise suspicion. Testing has limitations, and different testing methods may produce different results, which is why he places so much weight on the broader clinical picture.

 

What Is the Horowitz Lyme-MSIDS Questionnaire?

 

 

The Horowitz Lyme-MSIDS Questionnaire is a clinical screening tool designed to help organize a patient’s symptom burden, exposure history, and overall health into a more structured picture. 

 

Horowitz developed it because complex patients commonly arrive with dozens of symptoms but may only mention the few that feel most urgent, making important patterns easy to miss. The questionnaire helps practitioners capture the full presentation before deciding which symptoms and potential MSIDS factors deserve the most attention.

 

The questionnaire is divided into several sections. 

 

The first is the 38-item symptom frequency score, where each symptom is rated from none to severe. A second section gives additional weight to several symptoms Horowitz considers especially common in Lyme presentations. The questionnaire then adds a Lyme incidence score, which considers factors such as a history of tick exposure or rash, living in an endemic area, family history, migratory pain or neuropathy, certain prior diagnoses, and previous Lyme testing.

 

The final section looks at overall physical and mental health, asking how many days during the previous month the individual felt physically or mentally unwell. Scores from all sections are then combined into a final score. Within the questionnaire’s own scoring system, 46 or higher is considered a high probability of a tick-borne disorder, 21–45 suggests a possible tick-borne disorder, and below 21 is considered less likely. These cutoffs are intended to guide further evaluation, not establish a diagnosis on their own.

 

Why Symptoms Matter as Much as the Diagnosis

 

 

A diagnosis shouldn’t automatically become the explanation for every symptom a patient experiences. Instead, practitioners should identify the patient’s chief complaints and then work backward through the possible causes of each symptom. 

 

Neuropathy is a good example. A patient with an existing Lyme or mold diagnosis might understandably assume that new tingling, burning, numbness, or stabbing pain must come from that same condition. But Horowitz’s differential for neuropathy is much broader. Depending on the pattern and the individual, he considers possibilities such as Lyme, Bartonella, mold toxins, heavy metals including lead, arsenic, and mercury, metabolic dysfunction or diabetes, and nutrient abnormalities involving B12 or folate, in addition to other neurological causes.

 

This is where the MSIDS framework becomes especially useful for root-cause care. The goal is to ask “What could be causing this particular symptom in this particular individual?” Someone can have a legitimate chronic illness diagnosis and still develop symptoms from a completely different or overlapping problem. Assuming everything belongs to the existing diagnosis can create diagnostic tunnel vision and potentially leave another important contributor untreated.

 

Looking at symptoms this way also helps establish priorities. Rather than chasing every abnormality at once, the practitioner can identify the symptoms most limiting the patient’s quality of life, build a differential around each one, and look for causes that may explain several complaints simultaneously.

 

MSIDS and Other Chronic Illness Conditions

 

 

The MSIDS framework can also be applied to conditions that already have their own established diagnoses but often involve multisystem symptoms and overlapping contributors. MSIDS helps practitioners understand what other root causes could be driving the following conditions:

 

• Long COVID: Long COVID is particularly relevant because many of the same overlapping factors are in the long-COVID population. COVID can sometimes act as the trigger or tipping point, inviting practitioners to ask what else is burdening the system.   
• MCAS: Mast cell activation syndrome (MCAS) can become another important contributor or amplifier within a complex chronic illness picture. Mast cell activation is connected to gut permeability, microbiome disruption, histamine release, and inflammatory signaling, while infections, mold exposure, and nervous system or stress-related dysregulation can further influence that reactivity. 
• POTS and Dysautonomia: POTS and dysautonomia are specifically included within the MSIDS map because autonomic dysfunction can become a major source of ongoing disability, even while the original infection, toxin exposure, or other trigger is being addressed. Symptoms such as dizziness, abnormal heart-rate responses, low blood pressure, exercise intolerance, digestive changes, and temperature-regulation problems can significantly limit recovery. Horowitz evaluates autonomic function directly and emphasizes that it may need its own support rather than assuming it will automatically resolve when another MSIDS factor is treated.
• ME/CFS and Fibromyalgia: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia share substantial symptom overlap with MSIDS presentations. Horowitz specifically includes chronic fatigue syndrome and fibromyalgia among the complex chronic illnesses to which he applies the 16-point framework, and prior diagnoses of these conditions are also captured in his questionnaire. The purpose is to ask whether potential underlying or perpetuating drivers have been adequately investigated before concluding that the diagnostic label fully explains the illness.
• Autoimmune Disease: Autoimmune disease is another important area of overlap because immune dysfunction and autoimmunity are themselves part of the broader MSIDS map. Horowitz’s questionnaire specifically asks about diagnoses such as lupus, multiple sclerosis, rheumatoid arthritis, and nonspecific autoimmune conditions. From an MSIDS perspective, an autoimmune diagnosis remains clinically meaningful, but it can also prompt a broader investigation into the stressors that may be influencing immune regulation and contributing to the patient’s overall disease burden.

 

How Do You Know What to Treat First?

 

 

One of the most important parts of the MSIDS model is recognizing that identifying the factors isn’t the same as knowing the order in which to treat them. Horowitz describes his approach as personalized precision medicine, and this is also very similar to how we approach complex chronic illness in our functional practice. 

 

There is rarely one universal starting point. The more useful questions are: What appears to be the biggest driver right now? What can the patient realistically tolerate? What may be preventing other treatments from working? And which systems need to become more stable before the body can handle deeper root-cause treatment? 

 

For example, someone with severe digestive dysfunction, significant food intolerance, bloating, Candida overgrowth, or intestinal permeability likely needs the gut stabilized before aggressive antimicrobial treatment. 

 

The same principle applies across the rest of the MSIDS map. Depending on the individual, early priorities may include:

 

• Significant mold exposure or mold sensitivity: Address the environment and mold-related burden before pushing other treatment, particularly when exposure continues to provoke symptoms. It’s often recommended to delay Lyme treatment in highly mold-sensitive patients while first working on mold, the gut, autonomic dysfunction, and overall resilience.
• POTS or low blood pressure: Stabilize circulation and autonomic function so the patient is better able to tolerate subsequent treatment.
• Major mast cell or histamine instability: Reduce immune reactivity and improve tolerance before introducing therapies that could further increase inflammatory stress.
• Severe GI dysfunction: Support digestion, the microbiome, intestinal barrier, and bowel function before introducing more aggressive therapies.
• Nutrient depletion or mitochondrial dysfunction: Rebuild some of the basic resources needed for energy production, antioxidant defenses, immune function, and recovery.
• Meaningful infection burden: Use appropriately targeted antimicrobial treatment when the patient is stable enough, and the infection appears to be an important current driver.

 

Treatment also doesn’t always happen in perfectly separated phases. Treating multiple facets simultaneously may be required. In our practice, we take a similar approach: sometimes one factor clearly needs to come first, while other times several foundational areas can be supported simultaneously.

 

Does Treating the Infection Fix MSIDS?

 

 

Even when an important infection has been successfully addressed, that doesn’t automatically mean every downstream system will immediately return to normal. One of the central ideas behind the MSIDS model is that chronic illness can create layers of dysfunction that begin to take on lives of their own. 

 

Horowitz notes that patients tend to respond more completely when other overlapping factors are also under control.

 

For example, an infection may have been one of the original inflammatory drivers, but months or years of illness may have altered various bodily systems and created a cascade of downstream effects. Those issues may continue contributing to ongoing symptoms even after the infectious burden has improved. After addressing infections and toxins, foundation work can still be required and is essential for root-cause healing.

 

The Nervous System, Trauma, and the Cell Danger Response

 

 

Another important piece of the MSIDS framework is the relationship between chronic physiological stress, the nervous system, and the body’s ability to return to a healing state. 

 

Horowitz specifically includes autonomic nervous system dysfunction, neurological and psychological health, and trauma within the larger MSIDS picture. All the different drivers of MSIDs can represent forms of stress that the brain and body must continually respond to.

 

The cell danger response (CDR) is a proposed protective cellular response that occurs when cells perceive a significant threat. During danger, cellular priorities can shift away from normal energy production, repair, communication, and growth toward defense and survival. Mitochondria play an important role in this response because they do much more than produce energy; they also participate in cellular signaling and stress responses. 

 

The CDR is adaptive when danger is temporary, but the concern in chronic illness is that these protective patterns may fail to fully switch off after prolonged infection, toxin exposure, trauma, or other stressors have repeatedly signaled that the environment is unsafe. The mitochondria can become stuck in a dysfunctional danger-response state.

 

This is something we have come to appreciate deeply in our own clinical work. Nervous system regulation can be a missing piece of the root-cause healing puzzle, particularly for patients who have spent months or years living with unpredictable symptoms or fear of another flare. Even after the initial trigger improves, the nervous system may have become highly conditioned to scan for danger and respond defensively. That can influence everything from mast cell reactivity to pain perception and how resilient someone feels when treatment introduces another stressor.

 

For this reason, mind-body work such as limbic system retraining, vagal regulation, EMDR, cognitive behavioral therapy (CBT), meditation, and other strategies intended to help restore a greater sense of physiological and emotional safety are recommended. Patients with significant trauma or autonomic dysregulation sometimes can make progress with their physiological treatment but struggle to reach fuller recovery until this part of the picture is addressed as well.

 

The caveat here is essential: nervous-system regulation doesn’t replace treating physiological drivers of chronic illness or other foundational work. 

 

Removing the physiological trigger doesn’t always automatically restore a nervous system that has spent years operating in a threat state. This is why we view mind-body work as an adjunct to comprehensive root-cause care rather than an alternative to it. 

 

Healing usually requires reducing the genuine biological threats while also helping the brain and body relearn that they no longer need to respond to every sensation, food, environment, or stressor as though danger is still present. 

 

Pro-Tip: If nervous system regulation feels like a missing piece of your healing, our Wholeness Method was created specifically for individuals navigating complex chronic illness. This mind-body program is designed to complement root-cause treatment through personalized practices and evidence-informed tools. It can be especially valuable for those who have addressed many of the physical drivers of illness but still feel their body remains highly reactive or stuck in a persistent threat response and unable to tolerate different forms of treatment.

 

What Testing May Be Considered With MSIDS?

 

 

Horowitz recommends starting with a detailed clinical history, symptom pattern, chief complaints, and the Horowitz Lyme-MSIDS Questionnaire, and then using that information to build an individualized differential diagnosis. 

 

Testing is chosen to answer specific clinical questions rather than simply screening for every possible abnormality. In our functional practice, we take a similar approach because the right test, and the right time to run it, can vary significantly from one individual to another.

 

Depending on the individual presentation, evaluation may include:

 

• Clinical history and symptom assessment: A comprehensive history and symptom questionnaire help determine which areas of the MSIDS map warrant deeper investigation and which complaints should be prioritized first.
• Lyme/Borrelia testing: Testing may include conventional antibody-based testing as well as specialty immunoblot, PCR, or other methods when clinically appropriate. The specific approach depends on the history, previous testing, stage of illness, and practitioner’s differential.
• Bartonella testing: Bartonella can be particularly challenging to evaluate, and Horowitz discusses using multiple testing methodologies rather than depending on one assay. These may include specialty immunoblots, FISH, PCR-based methods, and antibody testing.
• Babesia and other infection testing: When symptoms or exposure history raise suspicion, testing may be considered for Babesia and other relevant infectious contributors. Horowitz describes specialty immunoblot and FISH testing among the options he uses for Babesia.
• Viral testing: Evaluation for active or reactivated viruses may be appropriate when the history suggests it, rather than routinely testing every virus in every patient.
• Mold, CIRS, and environmental evaluation: Depending on the presentation, this may involve investigating the home or workplace for ongoing exposure as well as considering appropriate clinical testing for mold- or biotoxin-related illness. Environmental evaluation can be just as important as biological testing when an exposure may still be occurring.
• Immune function: Immunoglobulins, subclasses, inflammatory or immune markers, and other immune testing may be useful when recurrent infections, unusual susceptibility, autoimmunity, or immune dysfunction are part of the picture. Looking for immunoglobulin and subclass deficiencies can be recommended in complex patients.
• GI and microbiome evaluation: Significant digestive symptoms may warrant stool testing, microbiome assessment, SIBO testing, or evaluation for fungal overgrowth and intestinal dysfunction. Comprehensive stool analysis, short-chain-fatty-acid-producing bacteria, SIBO, and possible SIFO evaluation may be recommended when the clinical picture points toward the gut.
• Nutrient status: Vitamins, minerals, and other nutritional markers may be assessed based on symptoms, diet, medications, absorption, and suspected deficiencies. Nutritional testing can also help identify factors affecting mitochondrial function, neurological health, immune resilience, and recovery.
• Hormonal and adrenal considerations: Thyroid, sex hormones, cortisol, DHEA, glucose-regulating hormones, and related markers may be considered when endocrine symptoms are present. 
• POTS and autonomic testing: Sitting and standing heart rate and blood pressure measurements can provide an initial assessment for orthostatic intolerance or POTS, with more formal autonomic testing considered when appropriate.
• Metabolic markers: Blood sugar regulation, insulin resistance, liver function, and other metabolic markers can be especially useful when symptoms such as fatigue, neuropathy, hypoglycemia, or metabolic dysfunction are present.
• Mitochondrial and cellular-energy considerations: Evaluation is generally guided by the clinical picture and may include nutritional, metabolic, oxidative-stress, or other markers that help identify factors interfering with cellular energy production.

 

Why MSIDS Testing Can Be Complicated

 

 

Different tests look for different things, and a negative result doesn’t necessarily answer every version of the clinical question. Antibody-based tests evaluate the immune response to an organism, while direct-detection methods such as PCR or FISH attempt to detect evidence of the organism itself.  

 

The species and strains included in a test also matter. Horowitz uses Bartonella as an example: a conventional panel may evaluate common species such as Bartonella henselae and B. quintana without necessarily assessing other species he encounters in his patient population. Babesia likewise includes multiple species that may need to be considered. This creates the possibility of an apparent negative result simply because the organism being investigated was not adequately represented by that particular test.

 

Timing and immune function can further complicate interpretation. Antibody production changes over the course of an illness, and previous treatment, stage of infection, and the patient’s immune response can all influence what a test is capable of detecting at a given moment. Immunoglobulin and B-cell abnormalities can be present in some chronically ill patients. When antibody production itself is impaired, it is reasonable for the clinician to consider that limitation when interpreting antibody-dependent testing rather than viewing a negative result in isolation.

 

This is why clinical context remains essential. Test results need to be interpreted alongside exposure history, symptom patterns, previous diagnoses and treatment, immune status, and the differential diagnoses being considered. Specialty laboratories such as IGeneX may offer immunoblots or other testing approaches that differ from standard laboratory testing, but that doesn’t mean every patient needs specialty testing or that one laboratory is universally superior. The useful question is whether a particular test is likely to answer a clinically meaningful question for that individual.

 

Timing should therefore be individualized as well. Some testing is valuable at the beginning of the workup, while other testing may make more sense later as new information emerges or the patient’s condition changes. 

 

Likewise, not every suspected contributor requires definitive specialty testing before lower-risk supportive care can begin. When history and symptoms strongly suggest a particular area of dysfunction, a practitioner may sometimes begin conservative interventions while reserving expensive or specialized testing for situations where the result would meaningfully change the treatment plan.

 

How Long Does MSIDS Recovery Take?

 

 

There is no universal timeline for MSIDS recovery because the number, severity, and order of the contributing factors can vary dramatically from one individual to another. 

 

Horowitz describes complex recovery as typically unfolding over many months and, in some cases, roughly a year or longer, largely because different drivers may need to be addressed sequentially and the response to each phase must be reassessed before deciding what comes next. Someone dealing with a more complex case may simply require more layers of care than someone with a narrower presentation.

 

However, taking a year to work through the larger picture doesn’t mean waiting a year to feel better. Patients may begin noticing meaningful changes within months even when complete recovery takes considerably longer.

 

In our clinical experience, we similarly want to see some meaningful improvement within roughly three to six months of a new protocol, depending on what is being treated and how complex the case is. If there is little or no movement over that timeframe, it can be a reason to reassess whether the correct driver is being targeted, whether another factor is blocking progress, or whether the treatment sequence needs to change.

 

For patients with years of illness and multiple layers of immune and inflammatory burden, the full healing process can sometimes take years. But there should be signs of progress along the way. 

 

Can You Recover From MSIDS?

 

 

Recovery from MSIDS is possible, and both Horowitz’s experience and what we have seen clinically reinforce an important message: chronic illness doesn’t necessarily mean permanent illness. 

 

We have worked with many individuals who came to us after years of symptoms, multiple diagnoses, and limited progress, yet still experienced meaningful improvements once the broader picture was addressed more comprehensively. Sometimes that means identifying a missed driver, changing the treatment sequence, stabilizing a system that had been overlooked, or simply giving the body enough time and support to regain resilience. 

 

Horowitz similarly shared examples of patients reaching long-term remission after multiple MSIDS factors were addressed rather than assuming longstanding illness could no longer improve.

 

We urge you not to give up simply because previous practitioners haven’t identified the full picture. There are always more avenues to explore, and healing can continue even after years of illness.

 

Finding a Practitioner Who Understands MSIDS

 

 

Because MSIDS involves multiple potential drivers and downstream effects, finding the right practitioner can make a significant difference in both the quality and efficiency of care. Ideally, the practitioner should be comfortable looking beyond one diagnosis, taking a thorough clinical history, building appropriate differential diagnoses, and deciding which areas deserve attention first. 

 

The practitioner needs to understand both the broader MSIDS framework and the nuances of applying it to the individual patient.

 

Look for a practitioner who:

 

• Is comfortable with complex chronic illness. They should be accustomed to patients with multisystem symptoms, long medical histories, and several overlapping diagnoses rather than expecting every case to fit neatly into one specialty.
• Understands Lyme and associated infections. Familiarity with Lyme/Borrelia, Bartonella, Babesia, viral reactivation, and other infectious considerations can be important when those factors are relevant to the clinical picture.
• Doesn’t attribute every symptom to one diagnosis. A good MSIDS-informed practitioner should continually ask what else could explain a symptom rather than assuming Lyme, mold, MCAS, or another existing diagnosis accounts for everything.
• Understands mold and environmental illness. Environmental exposures can be an important part of the MSIDS picture, so the practitioner should know when an exposure history, building evaluation, CIRS assessment, or other environmental investigation may be warranted.
• Evaluates the gut, immune, endocrine, metabolic, and autonomic systems. Horowitz emphasizes looking beyond infections to factors such as microbiome health, immune dysfunction, hormones, mitochondria, nutrition, sleep, and POTS/dysautonomia.
• Understands nervous-system regulation without psychologizing chronic illness. Trauma, autonomic dysregulation, and limbic or vagal dysfunction can be meaningful parts of recovery, but they should be addressed alongside physiological root causes.
• Uses individualized testing and treatment sequencing. The practitioner should be able to determine what is most important to investigate now, what can wait, what the patient can tolerate, and what may be blocking progress rather than automatically ordering every test or following the same protocol for everyone.
• Is willing to reassess when the patient isn’t improving. Complex cases evolve, and the original working hypothesis may need to change as symptoms, laboratory findings, tolerance, and treatment response provide new information. Horowitz repeatedly emphasizes looking across the full MSIDS map rather than remaining hyper-focused on one piece of the illness.

 

Pro-Tip: Our functional medicine practitioners at Empower Functional Health are well-versed in the MSIDS framework and complex chronic illness care. Our approach is similarly individualized—we work to understand the entire health picture, identify the most important priorities, and build a root-cause healing treatment sequence around what each patient needs and can realistically tolerate rather than relying on a single diagnosis or standardized protocol.

 

FAQs on MSIDS

Here are our most frequently asked questions about MSIDS:

Closing Thoughts: Chronic Illness Is a Puzzle

Complex chronic illness can be exhausting, especially when symptoms span multiple systems, testing feels inconclusive, or previous treatments have only helped part of the picture. The MSIDS framework offers a reminder that persistent illness is typically about identifying the combination of factors that may be keeping the body from fully recovering and addressing them in the right order.

 

Most importantly, a long history of illness doesn’t mean healing has reached its limit. 

 

There can always be overlooked drivers, better treatment sequencing, or additional areas of support that can create meaningful progress. Recovery may take time, but every improvement in resilience, function, tolerance, and quality of life matters—there is always value in continuing to ask better questions about what the body needs next.

 

Get a More Complete Picture of Your Chronic Illness

Our Empower Functional Health practice is honored to be trusted Carnivore diet functional medicine practitioners, supporting patients and clients from around the globe. We’re passionate about helping individuals achieve root-cause healing in order to live the life they are meant to, nearly symptom-free. We provide holistic health thought leadership and evidence-based insights, paired with clinical pearls, to help you achieve your wellness goals. We welcome you to explore our free resources, and if you find that self-troubleshooting falls short, we’re here to guide you with personalized support and protocols. Our Personalized Health Plan (PHP) is the ideal starting point for uncovering your root causes. You can learn more about this powerful, proprietary tool in-depth here. 

 

 

DISCLAIMER: We share this content to help you make informed and empowered decisions about your health. However, it is provided for educational purposes only and is not intended to diagnose, treat, cure, or prevent any condition or replace individualized medical advice. Always consult with a trusted, qualified healthcare practitioner before beginning a new diet, supplement, treatment, or health protocol.